On behalf of the Academy of Managed Care Pharmacy (AMCP), I wanted to take this opportunity to express our strong support for the Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act (S. 974), bipartisan legislation to increase competition and patient access to safe and affordable generic and biosimilar medicines.
AMCP CEO Blog: The White House made news last month with its blueprint to lower drug prices. But it's also important to note that biosimilars will play a crucial role in fostering competition and lowering costs.
Press Release: The Academy of Managed Care Pharmacy (AMCP) Foundation is delighted to announce that it collected 1,118 pairs of brand-new socks last month for individuals in need throughout the Boston area.